The health system entered into an agreement with Abridge and will use the company’s generative AI to address the challenges associated with clinical documentation, according to a Feb. 23 news release from Abridge.
The primary objective of the initial deployment of the technology is to alleviate the cognitive burden on clinicians, allowing them to devote more time to face-to-face patient interactions rather than being tied to computers.
Abridge also announced a $150 million series C investment, led by Lightspeed Venture Partners. Abridge recently closed out a $30 million series B funding round joined by Somerville, Mass.-based Mass General Brigham Artificial Intelligence and Digital Innovation Fund, Oakland, Calif.-based Kaiser Permanente Ventures and CVS Health Ventures.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
